⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23483170 | 0.79 | — | — | |
| SCHEMBL17928969 | 0.74 | — | — | |
| SCHEMBL17696303 | 0.74 | — | — | |
| SCHEMBL470814 | 0.73 | — | — | |
| SCHEMBL2596793 | 0.73 | — | — | |
| SCHEMBL18291426 | 0.69 | — | — | |
| SCHEMBL8520744 | 0.69 | — | — | |
| SCHEMBL21163705 | 0.68 | — | — | |
| SCHEMBL24729860 | 0.67 | — | — | |
| SCHEMBL21761799 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1804 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119842040-A | Post-crosslinking controlled-release nitric oxide amphiphilic polyurethane and preparation method and application thereof | 江苏鱼跃凯立特生物科技有限公司 | 2025-04-18 | — | — | CN | claimed |
| CN-119101020-A | Synthesis method of 3-oxetane carbonitrile | 凯美克(上海)医药科技有限公司 | 2024-12-10 | — | — | CN | claimed |
| CN-118841565-A | Positive electrode material matrix, preparation method thereof, positive electrode plate and sodium ion battery | 浙江锂威能源科技有限公司 | 2024-10-25 | — | — | CN | claimed |
| EP-4429872-A1 | VAT POLYMERIZATION PROCESS | Polyfos 3D Ltd (IL) | 2024-09-18 | — | — | EP | claimed |
| CN-117304143-A | Preparation method of 3-iodo-oxetane | 扬州市普林斯医药科技有限公司 | 2023-12-29 | — | — | CN | claimed |
| CN-117069770-A | Method for synthesizing N-heterocyclic carbene complex by utilizing hydrogen bond | 石河子大学 | 2023-11-17 | — | — | CN | claimed |
| WO-2023084517-A1 | VAT POLYMERIZATION PROCESS | POLYFOS 3D LTD (IL) | 2023-05-19 | — | — | WO | claimed |
| CN-115960121-A | Method for synthesizing 1- (3-oxa-cyclobutylcyclo-alkyl) -1H-pyrazole-4-boronic acid pinacol ester | 南通药明康德医药科技有限公司 | 2023-04-14 | — | — | CN | claimed |
| EP-4746965-A1 | BENZIMIDAZOLES AS SIK-ACTIVITY MODULATORS | F. Hoffmann-La Roche AG (CH) | 2026-05-27 | — | — | EP | disclosed |
| CN-122094678-A | AP 2-related kinase 1 inhibitors and uses thereof | — | 2026-05-26 | — | — | CN | disclosed |
| CN-116867788-B | 4-Aminoquinazoline compounds | ASTELLAS PHARMA INC. (JP) | 2026-05-26 | — | — | CN | disclosed |
| US-12637468-B2 | Substituted [1,2,4]triazolo[4,3-b]pyridazines as GABAA receptor modulators | Shanghai Simr Biotechnology Co., Ltd. (CN) | 2026-05-26 | — | — | US | disclosed |
| US-20260138956-A1 | NOVEL COMPOUNDS AND USES THEREOF | RECURSION PHARMACEUTICALS INC (US) | 2026-05-21 | — | — | US | disclosed |
| WO-2026107227-A1 | COMPOSITIONS COMPRISING USP1 INHIBITORS AND METHODS OF USING THE SAME | EIKON THERAPEUTICS, INC. (US) | 2026-05-21 | — | — | WO | disclosed |
| WO-2010117662-A1 | MODULATORS OF S1P AND METHODS OF MAKING AND USING | EXELIXIS, INC. (US) | 2010-10-14 | — | — | WO | disclosed |
| US-20100249071-A1 | Modulators of S1P and Methods of Making And Using | EXELIXIS, INC. (US) | 2010-09-30 | — | — | US | disclosed |
| US-20100249071-A1 | Modulators of S1P and Methods of Making And Using | EXELIXIS, INC. (US) | 2010-09-30 | — | — | US | disclosed |
| US-20100249071-A1 | Modulators of S1P and Methods of Making And Using | EXELIXIS, INC. (US) | 2010-09-30 | — | — | US | disclosed |
| WO-2009140624-A2 | GLUCOKINASE ACTIVATORS | TAKEDA SAN DIEGO, INC. (US) | 2009-11-19 | — | — | WO | disclosed |
| WO-2006060810-A1 | SULFONAMIDE COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS | SCHERING AKTIENGESELLSCHAFT (DE) | 2006-06-08 | — | — | WO | disclosed |